Kinase Inhibitors [MoA] class drugs

FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

11 results

ibrance - palbociclib capsule
(Palbociclib)
Medication Details
Pfizer Laboratories Div Pfizer Inc
Usage: IBRANCE treats HR-positive, HER2-negative advanced or metastatic breast cancer in adults, combined with an aromatase inhibitor or fulvestrant. Also indicated with inavolisib and fulvestrant for endocrine-resistant, PIK3CA-mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer after adjuvant endocrine therapy.
Medication Details
Savings Programs
1
Drug Interactions
ibrance - palbociclib capsule
(Palbociclib)
Medication Details
U.S. Pharmaceuticals
Medication Details
Drug Interactions
ibrance - palbociclib tablet, film coated
(Palbociclib)
Medication Details
Pfizer Laboratories Div Pfizer Inc
Medication Details
Drug Interactions
ibrance - palbociclib tablet, film coated
(Palbociclib)
Medication Details
U.S. Pharmaceuticals
Medication Details
Drug Interactions
lazcluze - lazertinib tablet, film coated
(Lazertinib)
Medication Details
Janssen Biotech, Inc.
Medication Details
Drug Interactions
lorbrena - lorlatinib tablet, film coated
(Lorlatinib)
Medication Details
Pfizer Laboratories Div Pfizer Inc
Usage: Lorbrena treats adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors test positive for anaplastic lymphoma kinase (ALK) mutations.
Medication Details
Savings Programs
1
Drug Interactions
lorbrena - lorlatinib tablet, film coated
(Lorlatinib)
Medication Details
U.S. Pharmaceuticals
Medication Details
Drug Interactions
pemazyre - pemigatinib tablet
(Pemigatinib)
Medication Details
Incyte Corporation
Usage: Pemazyre treats adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement, and adults with relapsed or refractory myeloid/lymphoid neoplasms with FGFR1 rearrangement.
Medication Details
Drug Interactions
tagrisso - osimertinib tablet, film coated
(Osimertinib)
Medication Details
Astrazeneca Pharmaceuticals Lp
Usage: TAGRISSO treats adults with EGFR mutation-positive non-small cell lung cancer (NSCLC): as adjuvant therapy after resection, for locally advanced unresectable stage III NSCLC post-chemoradiation, as first-line treatment for metastatic NSCLC (alone or with chemotherapy), and for T790M mutation-positive NSCLC after prior EGFR TKI therapy.
Medication Details
Drug Interactions
verzenio - abemaciclib tablet
(Abemaciclib)
Medication Details
Eli Lilly And Company
Usage: Verzenio (abemaciclib) treats HR-positive, HER2-negative breast cancer in adults. Used with endocrine therapy for high-risk early breast cancer, with an aromatase inhibitor or fulvestrant for advanced/metastatic disease, or as monotherapy after prior endocrine therapy and chemotherapy in the metastatic setting.
Medication Details
Drug Interactions

Kinase Inhibitors [MoA] class drugs

ibrance - palbociclib capsule

ibrance - palbociclib capsule

ibrance - palbociclib tablet, film coated

ibrance - palbociclib tablet, film coated

lazcluze - lazertinib tablet, film coated

lorbrena - lorlatinib tablet, film coated

lorbrena - lorlatinib tablet, film coated

pemazyre - pemigatinib tablet

tagrisso - osimertinib tablet, film coated

verzenio - abemaciclib tablet